Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.54 |
| ▸ | FEN1 | P39748 | 1/20 | 0.54 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.54 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.52 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.52 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.52 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | BRD4 | O60885 | 2/20 | 0.52 |
| ▸ | BRPF1 | P55201 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.50 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29798837 | 1.00 | CYP1A2 (0.55) | CYP1A2ERCC1FEN1ERCC4PIK3CD | |
| Hydrochloric Acid SCHEMBL30293270 | 0.97 | CYP1A2 (0.53) | CYP1A2ERCC1FEN1ERCC4PIK3CD | |
| SCHEMBL19117688 | 0.83 | CYP1A2 (0.47) | CYP1A2ERCC1FEN1ERCC4ALDH1A1 | |
| SCHEMBL5143886 | 0.83 | CYP1A2 (0.47) | CYP1A2ERCC1FEN1ERCC4ALDH1A1 | |
| SCHEMBL1520214 | 0.83 | ERCC1 (0.66) | CYP1A2ERCC1FEN1ERCC4ALDH1A1 | |
| SCHEMBL5966706 | 0.83 | CYP1A2 (0.47) | CYP1A2ERCC1FEN1ERCC4ALDH1A1 | |
| SCHEMBL627253 | 0.83 | CYP1A2 (0.47) | CYP1A2ERCC1FEN1ERCC4ALDH1A1 | |
| SCHEMBL28595121 | 0.83 | CYP1A2 (0.47) | CYP1A2ERCC1FEN1ERCC4ALDH1A1 | |
| SCHEMBL13838140 | 0.83 | CYP1A2 (0.47) | CYP1A2ERCC1FEN1ERCC4ALDH1A1 | |
| SCHEMBL1278798 | 0.82 | GABRA5 (0.55) | CYP1A2ERCC1FEN1ERCC4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119118925-B | Preparation method and application of benzimidazole-2-ketone derivative | 中国人民解放军陆军军医大学 | 2025-05-27 | — | — | CN | claimed |
| CN-119789670-A | Perovskite solar cell and preparation method thereof | 中建科工集团有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119118925-A | Preparation method and application of benzimidazole-2-ketone derivative | 中国人民解放军陆军军医大学 | 2024-12-13 | — | — | CN | claimed |
| CN-118724984-A | Adsorption type film-forming corrosion inhibitor with high stability and preparation method thereof | 江苏创新石化有限公司 | 2024-10-01 | — | — | CN | claimed |
| US-20130109672-A1 | ACTIVATORS OF HUMAN PYRUVATE KINASE | THE UNITED STATES OF AMERICA,AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICE (US) | 2013-05-02 | — | — | US | claimed |
| US-7666977-B2 | Poly(carbonate-co-urea) copolymers and melt transesterification method of preparing these copolymers | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-02-23 | — | — | US | claimed |
| US-7557175-B2 | Poly(carbonate-co-urea) copolymers and melt transesterification method of preparing these copolymers | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2009-07-07 | — | — | US | claimed |
| US-7541372-B2 | Aryl-isoxazolo-4-yl-oxadiazole derivatives | HOFFMAN-LA ROCHE INC. (US) | 2009-06-02 | — | — | US | claimed |
| WO-2008136842-A1 | POLY( CARBONATE-CO-UREA) COPOLYMERS | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-11-13 | — | — | WO | claimed |
| WO-2008136841-A1 | POLY(CARBONATE-CO-UREA) COPOLYMERS AND MELT TRANSESTERIFICATION METHOD OF PREPARING THESE COPOLYMERS | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-11-13 | — | — | WO | claimed |
| EP-1036055-B1 | METHOD FOR PRODUCING CHLOROCARBOXYLIC ACID CHLORIDES | BASF AG (DE) | 2002-03-27 | — | — | EP | claimed |
| US-6262300-B1 | REACTING THE CORRESPONDING LACTONE WITH PHOSPGENE IN PRESENCE OF UREA | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-17 | — | — | US | claimed |
| US-6245954-B1 | PREPARING ALKYL, ALKENYL AND ALKYNYL CHLORIDES FROM ALCOHOLS BY REACTION WITH CHLORINATING AGENT IN PRESENCE OF UREA COMPOUND AS CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-12 | — | — | US | claimed |
| EP-1036055-A2 | METHOD FOR PRODUCING CHLOROCARBOXYLIC ACID CHLORIDES | BASF AKTIENGESELLSCHAFT (DE) | 2000-09-20 | — | — | EP | claimed |
| WO-1999029648-A2 | METHOD FOR PRODUCING CHLOROCARBOXYLIC ACID CHLORIDES | BASF AKTIENGESELLSCHAFT (DE) | 1999-06-17 | — | — | WO | claimed |
| US-5518891-A | SUBSTITUTED ANILINES, HYDRAZONES OR 4-AMINOANTIPYRINES | ACTIMED LABORATORIES, INC. (US) | 1996-05-21 | — | — | US | claimed |
| US-4469874-A | ALKYL THIOSALICYLATES | MONSANTO COMPANY (US) | 1984-09-04 | — | — | US | claimed |
| US-4367235-A | CARDIOVASCULAR DISORDERS | BOEHRINGER MANNHEIM GMBH (DE) | 1983-01-04 | — | — | US | claimed |
| EP-0000784-B1 | 4-HYDROXY-2-BENZIMIDAZOLINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICAMENTS | Roche Diagnostics GmbH (DE) | 1981-08-26 | — | — | EP | claimed |
| US-4283508-A | Fragrant prevulcanization inhibitors | MONSANTO COMPANY (US) | 1981-08-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109672-A1 | ACTIVATORS OF HUMAN PYRUVATE KINASE | PDK2, PDK1, PKLR | CYP1A2 1258/4885ERCC1 3840/4885FEN1 3581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.